Strategic Advisory

AdviseClinical will help you maximize the potential of your clinical development efforts, existing products and IP portfolio. Creating a faster path to your strategic goals is what drives our corporate culture. Expertise and insight into the ever changing healthcare market enable more efficient opportunity assessment and maximization of product pipelines. AdviseClinical has access to a broad range of enhanced capabilities, experts and industry partners and can guide the implementation and execution of your products’ development lifecycle.
  • The principals of AdviseClinical have undertaken over 260 market or opportunity assessments on medical product technologies
  • The team has developed a codified assessment framework which can used to determine the economic value of a product in the context of various market scenarios
  • Specifically, the methodology seeks to highlight the value attached to each product attribute in the TPP
  • AdviseClinical has developed a Portfolio Management tool that uses the outputs of the Market Opportunity process to evaluate the overall portfolio and its economic value
  • Market access research
  • Pricing and reimbursement services
  • Patient-reported outcomes
  • Economic analysis (burden of illness, cost effectiveness, cost utility)
  • Advanced econometric methods
  • Decision analytic modeling
  • Comparative effectiveness research
  • Utilization data (treatment patterns, switching, utilization patterns)
  • Productivity outcomes
  • Searchable databases by CPT, Rx, ICD9
  • Access to Therapeutic Specific Databases
  • Data aggregation from EMR, claims, Rx data
  • The principles of AdviseClinical have collectively been involved in over 100 funding situations
  • AdviseClinical has a network of 200 Venture Capital, Private Equity and Sovereign Wealth Executives
  • Understanding of current investments, size of fund, therapeutic or business area emphasis (e.g. drug, services, devices, etc.), position of the fund in terms of funds deployed to date and maturity and size of fund